No products from this compounder that are marked as sterile should be administered to patients, as microbial contamination can put patients at risk for severe infections.
Hospitals and healthcare providers should quarantine any such products and await further instructions, according to the release.
More Articles on Anesthesia:
Sedasys Computer-Assisted System for GI Propofol Sedation Approved by FDA
FDA Clears Masimo’s Rainbow Respiratory Monitor for Pediatric Use
Hospira GemStar Infusion System Recalled by FDA for Battery Malfunction
Register to Attend Webinar
Presenters:
James Germano, MD, Joint Reconstruction Specialist|Tim Tzimas, Innovative Sterilization Technologies
Next Up in Legal & Regulatory Issues
-
The Wake County (N.C.) board of commissioners voted 5-2 on Sept. 21 to approve the proposed combination of Raleigh, N.C.-based…
-
Joplin, Mo.-based Freeman Health System and Fort Scott, Kan.-based Kansas Renewal Institute have signed a nonbinding letter of intent to…
-
Financial pressure is accelerating consolidation at a pace not seen in years. Staffing shortages, aging infrastructure, heavy Medicaid and Medicare…
Join the 500,000+ healthcare executives who start their day with Becker's
Becker's Hospital Review Newsletter is sent Monday–Sunday.
